← Leaderboards
Guangshun Wang
University Of Nebraska Medical Center
$4,880,458
Attributed
$6,368,797
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $922.7K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,368,797 · 9
By mechanism
R01$4,078,613 · 2
R56$1,453,204 · 4
R21$395,566 · 1
P30$290,914 · 1
R03$150,500 · 1
Top collaborators
- Jingwei Xie5 shared
- Robert Walter Buckheit2 shared
- Daryl Murry1 shared
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Daryl Murry$191,875
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionResistanceBasePeptidesDesignDatabasesAntimicrobialAntimicrobial PeptideCessation Of LifeIn VivoStructureEngineeringPreventImmune ResponseMembranePathogenAntibioticsStaphylococcus AureusImmunoregulationMicrobial BiofilmsMolecularIn VitroLaboratoriesGenes
Grant awards (23)
Novel Janus-type Antimicrobial Dressings for the Treatment of Biofilms in Chronic Wounds$538,970
R01 · FY2023 · GM
Novel antimicrobials to combat Gram-negative bacteria$383,750
R56 · FY2023 · AI · contact PI
Novel Janus-type Antimicrobial Dressings for the Treatment of Biofilms in Chronic Wounds$538,970
R01 · FY2022 · GM
Novel Janus-type Antimicrobial Dressings for the Treatment of Biofilms in Chronic Wounds$529,074
R01 · FY2021 · GM
Novel Janus-type Antimicrobial Dressings for the Treatment of Biofilms in Chronic Wounds$102,349
R01 · FY2021 · GM
Novel Janus-type Antimicrobial Dressings for the Treatment of Biofilms in Chronic Wounds$488,000
R01 · FY2020 · GM
T-cell-Alveolar Macrophage Crosstalk during Influenza and Streptococcus Pneumoniae Co-infection$418,779
R56 · FY2019 · AI · contact PI
Database designed novel anti-MRSA peptides$376,250
R01 · FY2019 · AI · contact PI
Database designed novel anti-MRSA peptides$376,250
R01 · FY2018 · AI · contact PI
Surface antimicrobial coating to prevent bacterial biofilms$75,250
R03 · FY2018 · AI · contact PI
Database designed novel anti-MRSA peptides$376,250
R01 · FY2017 · AI · contact PI
Surface antimicrobial coating to prevent bacterial biofilms$75,250
R03 · FY2017 · AI · contact PI
Database designed novel anti-MRSA peptides$376,250
R01 · FY2016 · AI · contact PI
Database designed novel anti-MRSA peptides$376,250
R01 · FY2015 · AI · contact PI
Database designed novel anti-MRSA peptides$353,675
R56 · FY2013 · AI · contact PI
Development of Antimicrobial Peptides as Topical Microbicides$195,117
R21 · FY2011 · AI
Human Cathelicidin-Based Novel Antimicrobial Peptides$297,000
R56 · FY2010 · AI · contact PI
Development of Antimicrobial Peptides as Topical Microbicides$200,449
R21 · FY2010 · AI
CORE--NMR$82,218
P30 · FY2008 · CA · contact PI
CORE--NMR$96,428
P30 · FY2007 · CA · contact PI
CORE--NMR$38,535
P30 · FY2006 · CA · contact PI
CORE--NMR$37,412
P30 · FY2005 · CA
CORE--NMR$36,321
P30 · FY2004 · CA